New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.
J Thorac Oncol. 2013 May;8(5):612-8. doi: 10.1097/JTO.0b013e318287c3eb.
J Thorac Oncol. 2013.
PMID: 23584293
Free article.